Subscribe to RSS
Download PDF
DOI: 10.1055/a-1881-7441
Der Weg zur Diagnose – wann Sie bei Atemwegsbefunden an eine Vaskulitis denken müssen
The road to diagnosis – when to think of vasculitis in respiratory findings
ZUSAMMENFASSUNG
Durch bessere diagnostische Verfahren und therapeutische Optionen rücken die Lungenbeteiligungen von Autoimmunerkrankungen in den letzten Jahren immer mehr in den Fokus. Es finden sich auch bei Vaskulitiden häufig Atemwegsbeschwerden, die in Bezug auf Morbidität und Mortalität nicht selten auch die dominierende Manifestation sind. Dabei unterscheiden sich die Lungenbefunde bei den Vaskulitiden im Detail erheblich. Bei Auswahl der Diagnostik und der anschließenden Therapie muss dies berücksichtigt und vor allem von infektiösen Komplikationen differenziert werden. Da die Symptome unspezifisch sind, bedürfen die Behandler zwingend weiterer fachärztlicher Befunde aus Labor, Bildgebung und Histologie, um eine korrekte Diagnose treffen zu können. Dieser Beitrag möchte Sie unterstützen, vom Ausgangspunkt eines Leitsymptoms oder pathologischer Bildgebung zur Möglichkeit einer ursächlichen Vaskulitis Stellung nehmen zu können.
ABSTRACT
Due to better diagnostic procedures and therapeutic options, pulmonary involvement of autoimmune diseases has come more and more in focus in recent years. Respiratory symptoms are also frequently found in vasculitides, which are not infrequently also the dominant manifestation in terms of morbidity and mortality. Thereby, the pulmonary findings differ considerably in detail in the vasculitides. This must be considered when selecting diagnostics and subsequent therapy and, above all, differentiated from infectious complications. Because symptoms are nonspecific, practitioners absolutely require further expert laboratory, imaging, and histologic findings to make a correct diagnosis. This article aims to assist you in taking a position from the starting point of a leading symptom or pathologic imaging to the possibility of causative vasculitis.
Publication History
Article published online:
05 November 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Imran TF, Helfgott S. Respiratory and otolaryngologic manifestations of giant cell arteritis. Clin Exp Rheumatol 2015; 33: 164-170
- 2 Sacoto G, Boukhlal S, Specks U. et al Lung involvement in ANCA-associated vasculitis. Presse Med 2020; 49 (03) 104039
- 3 Csernok E, Mahrhold J, Hellmich B. Anti-neutrophil cytoplasm antibodies (ANCA): Recent methodological advances-Lead to new consensus recommendations for ANCA detection. J Immunol Methods 2018; 456: 1-6
- 4 Karras A. Microscopic polyangiitis: new insights into pathogenesis, clinical features and therapy. Semin Respir Crit Care Med 2018; 39: 459-464
- 5 Walsh M, Merkel PA, Peh CA. et al Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. N Engl J Med 2020; 382: 622-631
- 6 Papo M, Sinico RA, Teixeira V. et al Significance of PR3-ANCA positivity in eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Rheumatology (Oxford) 2021; 60: 4355-4360
- 7 Folci M, Ramponi G, Solitano V. et al Serum ANCA as Disease Biomarkers: Clinical Implications Beyond Vasculitis. Clin Rev Allergy Immunol. 2021 Epub ahead of print
- 8 Daum TE, Specks U, Colby TV. et al Tracheobronchial involvement in Wegener’s granulomatosis. Am J Respir Crit Care Med 1995; 151: 522-526
- 9 Sy A, Khalidi N, Dehghan N. et al Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. Semin Arthritis Rheum 2016; 45: 475-482
- 10 Csernok E, Trabandt A, Müller A. et al Cytokine profiles in Wegener’s granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum 1999; 42: 742-750 42:4 < 742::AIDL42:DASHANR18 > 3.0.CO;2L42:DASHI.L42:URLEND PMID: 10211889
- 11 Chang SY, Keogh KA, Lewis JE. et al IgG4-Positive Plasma Cells in Granulomatosis with Polyangiitis (Wegener’s): A Clinicopathologic and Immunohistochemical Study on 43 Granulomatosis with Polyangiitis and 20 Control Cases. Hum Pathol 2013; 44: 2432-2437
- 12 Mahr A, Batteux F, Tubiana S. et al Brief report: prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheumatol 2014; 66: 1672-1677
- 13 Yoshifuji A, Hibino Y, Komatsu M. et al Glomerulonephritis caused by Bartonella spp. infective endocarditis: the difficulty and importance of differentiation from anti-neutrophil cytoplasmic antibody-related rapidly progressive glomerulonephritis. Intern Med 2021; 60: 1899-1906
- 14 Robson JC, Grayson PC, Ponte C. et al 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Annals of the Rheumatic Diseases 2022; 81: 315-320
- 15 Grayson PC, Ponte C, Suppiah R. et al 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis Annals of the Rheumatic Diseases. 2022; 81: 309-314
- 16 Suppiah R, Robson JC, Grayson PC. et al 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Annals of the Rheumatic Diseases 2022; 81: 321-326